The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Jonnalagada, Subbanna ^a   Harries, Anthony D ^b,c   Zachariah, Rony ^d   Satyanarayana, Srinath ^e   Tetali, Shailaja ^f   Keshav Chander, G ^g   Rao, Srinivas ^g   Rao, Ranganadha ^a   Peri, Sundaresh ^a   Anchala, Raghupathy ^f   Kannuri, Nanda K ^f  

^a LEPRA Society   (India)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MÉDECINS SANS FRONTIÈRES   (Belgium)

^e Regional Office   (India)

^f PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^g Government of Andhra Pradesh   (India)

Author keywords

Death; India; Timing of death; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; INDIA; LUNG TUBERCULOSIS; MALE; MEDICAL AUDIT; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; INDIA; MALE; MEDICAL AUDIT; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 83255164931     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-921     Document Type: Article

References (24)

1. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi. Harries AD, Nyangulu DS, Kang'ombe C, Ndalama D, Glynn JR, Banda H, Wirima JJ, Salaniponi FM, Liomba G, Maher D, Nunn P, Trans Roy Soc Trop Med & Hyg 1998 92 343 347 10.1016/S0035-9203(98)91036-7 1397320 (Pubitemid 28286941)
2. High early mortality in tuberculosis patients in Malawi. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FML, Int J Tuberc Lung Disease 2001 5 1000 1005 (Pubitemid 33134749)
3. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. Diul Mukadi Ya, Maher D, Harries AD, AIDS 2001 15 143 152 10.1097/00002030-200101260-00002 11216921 (Pubitemid 32142288)
4. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Salaniponi FML, Lancet 2001 357 1519 1523 10.1016/S0140-6736(00)04639-0 11377627 (Pubitemid 32488877)
5. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? Zachariah R, Fitzgerald M, Massaquoi M, Acabu A, Chilomo D, Salaniponi FML, Harries AD, Int J Tuberc Lung Disease 2007 11 848 853 (Pubitemid 47232261)
6. Mortality among tuberculosis patients on treatment in Singapore. Low S, Ang LW, Cutter J, James L, Chee CBE, Wang YT, Chew SK, Int J Tuberc Lung Disease 2009 13 328 334
7. Risk factors for death during tuberculosis treatment in Orel, Russia. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B, Int J Tuberc Lung Disease 2004 8 598 602 (Pubitemid 38625066)
8. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT, Int J Tuberc Lung Disease 2009 13 105 111
9. WHO Report 2010. Global Tuberculosis Control. World Health Organization, WHO/HTM/TB/2010 Geneva: Switzerland 7
10. Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course. Pardeshi G, Indian J Med Sci 2009 63 180 186 10.4103/0019-5359.53163 19584488
11. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, Narayanan PR, Int J Tuberc Lung Disease 2002 6 780 788 (Pubitemid 34988048)
12. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, the STROBE initiative, Lancet 2007 370 1453 1457 10.1016/S0140-6736(07)61602-X 18064739
13. th March 2011)
14. Multidrug and extensively drug-resistant TB (M/XDR-TB). World Health Organization, 2010 Global Report on Surveillance and Response Geneva: Switzerland
15. Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Kolappan C, Subramani R, Kumaraswami T, Santha T, Narayanan PR, Int J Tuberc Lung Dis 2008 12 81 86 18173882
16. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Levebvre N, Falzon D, Eur Respir J 2008 31 1256 1260 10.1183/09031936.00131107 18515556
17. Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006. Jha UM, Satyanarayana S, Dewan PK, Chadha S, Wares F, Sahu S, Gupta D, Chauhan LS, PLoS ONE 2010 5 8873 10.1371/journal.pone.0008873 20111727
18. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Due C, Unwin N, BMC Public Health 2007 7 234 10.1186/1471-2458-7-234 17822539 (Pubitemid 47546161)
19. Diabetes and the risk of tuberculosis: a neglected threat to public health. Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, Unwin NC, Chronic Illness 2007 3 228 245 10.1177/1742395307081502 18083679 (Pubitemid 351927860)
20. Tuberculosis and diabetes mellitus: convergence of two epidemics. Dooley KE, Chaisson RE, Lancet Infect Dis 2009 9 737 746 10.1016/S1473-3099(09)70282-8 19926034
21. Implications of the global increase of diabetes for tuberculosis control and patient care. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJAM, van Crevel R, Trop Med Int Health 2010 15 1289 1299 10.1111/j.1365-3156.2010.02625.x 20955495
22. Registering initial defaulters and reporting on their treatment outcomes. Harries AD, Rusen ID, Chiang CY, Hinderaker SG, Enarson DA, Int J Tuberc Lung Dis 2009 13 801 803 19555527
23. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, Ottmani SE, Goonesekera SD, Murray MB, BMC Medicine 2011 9 81 10.1186/1741-7015-9-81 21722362
24. The Global Plan to Stop TB 2011-2015. World Health Organization, Geneva: Switzerland